Patent ID: 9248123
Filing Date: 2016-02-02
CPC Classification: A61K,A61P,Y10S

Claim Text:
1. A method for providing weight loss therapy to a patient, comprising: identifying an overweight or obese patient who is suffering from major depressive disorder; and reducing weight of the patient by administering to the patient a pharmaceutical weight loss therapy comprising naltrexone or a pharmaceutically acceptable salt thereof and bupropion or a pharmaceutically acceptable salt thereof, wherein the amount of naltrexone or pharmaceutically acceptable salt thereof is about 32 mg per day and the amount of the bupropion or pharmaceutically acceptable salt thereof is about 360 mg per day, and wherein said method provides about the same amount of weight loss in overweight or obese patients who are suffering from major depressive disorder as in overweight or obese patients who are not suffering from major depressive disorder.